BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/28/2025 3:10:35 AM | Browse: 12 | Download: 33
 |
Received |
|
2025-09-01 09:40 |
|
Peer-Review Started |
|
2025-09-01 09:41 |
|
First Decision by Editorial Office Director |
|
2025-09-22 09:40 |
|
Return for Revision |
|
2025-09-22 09:40 |
|
Revised |
|
2025-09-25 11:30 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-16 02:53 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-16 08:47 |
|
Articles in Press |
|
2025-10-16 08:47 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-21 01:30 |
|
Publish the Manuscript Online |
|
2025-11-28 03:10 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Risk elements and diagnostic indicators for asymptomatic immune checkpoint inhibitor-associated myocarditis in esophageal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Tushar Bhadra and Brandon Lucke-Wold |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Brandon Lucke-Wold, MD, Lillian S. Wells Department of Neurosurgery, University of Florida, 1505 SW Archer Rd, Gainesville, FL 32608, United States. brandon.lucke-wold@neurosurgery.ufl.edu |
| Key Words |
Risk factor; Immunotherapy; Esophageal cancer; Immune checkpoint inhibitors; Myocarditis |
| Core Tip |
Immune checkpoint inhibitors, which play a significant role in esophageal cancer therapy, can cause myocarditis in these patients. Several risk factors, such as advanced age, male sex, elevated creatine kinase (CK) and CK isoenzymes, contribute to this phenomenon. All these indicators can be combined into a single model to aid in early detection and personalized risk management. Prospective cohort studies with large sample sizes should be conducted, utilizing modern imaging modalities like magnetic resonance imaging. |
| Publish Date |
2025-11-28 03:10 |
| Citation |
Bhadra T, Lucke-Wold B. Risk elements and diagnostic indicators for asymptomatic immune checkpoint inhibitor-associated myocarditis in esophageal cancer. World J Gastroenterol 2025; 31(44): 113689 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i44/113689.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i44.113689 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
